https://scholars.lib.ntu.edu.tw/handle/123456789/535292
標題: | Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: A case-control study | 作者: | Lo Y.-C. Chen M.-Y. WANG-HUEI SHENG SZU-MIN HSIEH HSIN-YUN SUN Liu W.-C. Wu P.-Y. Wu C.-H. CHIEN-CHING HUNG SHAN-CHWEN CHANG |
公開日期: | 2009 | 卷: | 10 | 期: | 5 | 起(迄)頁: | 302-309 | 來源出版物: | HIV Medicine | 摘要: | Objectives: Recent studies suggest that patients with HIV infection are at increased risk for incident diabetes mellitus (DM). We investigated the incidence and risk factors of DM among HIV-infected patients receiving combination antiretroviral therapy (CART) in Taiwan. Methods: Incident cases of DM were identified among HIV-infected patients at the National Taiwan University Hospital between 1993 and 2006. A retrospective case-control study was conducted after matching cases with controls for sex, age at HIV diagnosis, year of HIV diagnosis, mode of HIV transmission and baseline CD4 lymphocyte count. A multivariate analysis was performed to identify risk factors for incident DM among HIV-infected patients. Results: In 824 HIV-infected patients eligible for analysis, 50 cases of incident DM were diagnosed, resulting in an incidence of 13.1 cases per 1000 person-years of follow-up. In total, 100 matched controls were identified. Risk factors for incident DM were a family history of DM [odds ratio (OR) 2.656; 95% confidence interval (CI) 1.209-5.834], exposure to zidovudine (OR 3.168; 95% CI 1.159-8.661) and current use of protease inhibitors (OR 2.528; 95% CI 1.186-5.389). Conclusions: Incident DM was associated with a family history of DM, exposure to zidovudine and current use of protease inhibitors in HIV-infected patients receiving CART in Taiwan. ? 2009 British HIV Association. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-65449131159&doi=10.1111%2fj.1468-1293.2008.00687.x&partnerID=40&md5=6afae5cf08594fdc7ef100faa2730293 https://scholars.lib.ntu.edu.tw/handle/123456789/535292 |
ISSN: | 1464-2662 | DOI: | 10.1111/j.1468-1293.2008.00687.x | SDG/關鍵字: | abacavir; antiretrovirus agent; atazanavir; didanosine; efavirenz; indinavir; lamivudine; lopinavir; nelfinavir; nevirapine; proteinase inhibitor; ritonavir; RNA directed DNA polymerase inhibitor; saquinavir; stavudine; zalcitabine; zidovudine; adolescent; adult; article; case control study; CD4 lymphocyte count; combination chemotherapy; controlled study; diabetes mellitus; drug exposure; family history; female; follow up; human; Human immunodeficiency virus infected patient; Human immunodeficiency virus infection; major clinical study; male; morbidity; priority journal; retrospective study; risk factor; Taiwan; virus transmission; Adolescent; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; China; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epidemiologic Methods; Family Health; Female; HIV Infections; Humans; Male; Middle Aged; Taiwan; Young Adult; Zidovudine |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。